JBS N.V. (JBS) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the JBS SEC filings page.
JBS N.V. (JBS) reported $86.2B in revenue for fiscal year 2025, up 11.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue is still expanding, but higher costs and heavier reinvestment are converting growth into less free cash.
In FY2025, revenue grew11.7% while cost of revenue grew14.2% , so growth was being absorbed by costs rather than dropping through to earnings. Operating cash flow remained above net income, but its conversion ratio fell from239.4% in FY2024 to144.8% , indicating weaker cash conversion despite positive earnings.
The balance sheet is more leveraged than a profit-only view suggests: liabilities represented 80.7% of assets and debt stood at 2.3x equity in FY2025. A current ratio of 1.6x provides reported short-term coverage, but the business is not lightly financed.
Free cash flow fell from
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of JBS N.V.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
JBS N.V. has an operating margin of 4.8%, meaning the company retains $5 of operating profit per $100 of revenue. This results in a moderate score of 49/100, indicating healthy but not exceptional operating efficiency. This is down from 5.7% the prior year.
JBS N.V.'s revenue grew 11.7% year-over-year to $86.2B, a solid pace of expansion. This earns a growth score of 61/100.
JBS N.V. has elevated debt relative to equity (D/E of 2.33), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 26/100, reflecting increased financial risk.
JBS N.V.'s current ratio of 1.60 indicates adequate short-term liquidity, earning a score of 46/100. The company can meet its near-term obligations, though with limited headroom.
While JBS N.V. generated $2.9B in operating cash flow, capex of $2.1B consumed most of it, leaving $832.7M in free cash flow. This results in a low score of 32/100, reflecting heavy capital investment rather than weak cash generation.
JBS N.V. earns a strong 23.3% return on equity (ROE), meaning it generates $23 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 81/100. This is down from 24.9% the prior year.
JBS N.V. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.
For every $1 of reported earnings, JBS N.V. generates $1.45 in operating cash flow ($2.9B OCF vs $2.0B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
JBS N.V. earns $2.48 in operating income for every $1 of interest expense ($4.2B vs $1.7B). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
JBS N.V. generated $23.9B in revenue in Q2 2026.
JBS N.V.'s EBITDA was $1.9B in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization.
JBS N.V. reported a net loss of $102.1M in Q2 2026.
Cash & Balance Sheet
JBS N.V. recorded an outflow of $1.1B in free cash flow in Q2 2026, representing a cash shortfall after capex.
JBS N.V. held $3.5B in cash against $21.3B in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
JBS N.V.'s gross margin was 10.8% in Q2 2026, indicating the percentage of revenue retained after direct costs.
JBS N.V.'s operating margin was 2.5% in Q2 2026, reflecting core business profitability.
JBS N.V.'s net profit margin was -0.4% in Q2 2026, showing the share of revenue converted to profit.
JBS N.V.'s quarterly ROE was -1.2% in Q2 2026: one quarter's net income over shareholder equity, not annualized.
Capital Allocation
JBS N.V. invested $1.2B in capex in Q2 2026, funding long-term assets and infrastructure.
Not reported for Q2 2026.
Not reported for Q2 2026.
JBS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q4'2520-F | Q3'256-K | Q4'2420-F | Q3'246-K |
|---|---|---|---|---|---|
| Revenue | $23.9B | N/A | $22.6B+13.4% | N/A | $19.9B |
| Cost of Revenue | $21.3B | N/A | $19.6B+17.9% | N/A | $16.6B |
| Gross Profit | $2.6B | N/A | $3.0B-9.4% | N/A | $3.3B |
| Operating Income | $597.1M | N/A | $1.2B-21.6% | N/A | $1.6B |
| EBITDA | $1.9B | N/A | N/A | N/A | N/A |
| Interest Expense | $528.9M | N/A | $480.2M+20.2% | N/A | $399.4M |
| Income Tax | -$125.9M | N/A | $171.2M-61.1% | N/A | $440.5M |
| Net Income | -$102.1M | N/A | $580.9M-16.2% | N/A | $692.9M |
| EPS (Basic) | -$0.10 | $0.44+2.3% | $0.52-16.1% | $0.43 | $0.62 |
| EPS (Diluted) | -$0.09 | $0.44+2.3% | $0.52-16.1% | $0.43 | $0.62 |
Not reported in any period shown, so not listed: R&D Expenses, SG&A Expenses, Diluted Shares (Avg).
JBS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q4'2520-F | Q3'256-K | Q4'2420-F | Q3'246-K |
|---|---|---|---|---|---|
| Total Assets | $45.8B | $45.2B+11.0% | $44.2B | $40.7B | N/A |
| Current Assets | $17.8B | $18.4B+7.7% | $17.7B | $17.1B | N/A |
| Cash & Equivalents | $3.5B | $4.6B-18.7% | $3.6B-29.8% | $5.6B | $5.1B |
| Inventory | $7.0B | $6.1B+21.8% | $6.6B | $5.0B | N/A |
| Goodwill | $6.0B | $5.9B+8.0% | $5.9B | $5.4B | N/A |
| Total Liabilities | $37.6B | $36.5B+8.5% | $35.5B | $33.6B | N/A |
| Current Liabilities | $11.6B | $11.5B-1.0% | $11.0B | $11.7B | N/A |
| Non-Current Liabilities | $25.2B | $24.1B+15.3% | $23.6B | $20.9B | N/A |
| Long-Term Debt | $21.3B | $20.3B+17.5% | $19.8B | $17.2B | N/A |
| Total Equity | $8.2B | $8.7B+22.7% | $8.7B-8.0% | $7.1B | $9.5B |
| Retained Earnings | $118.5M | N/A | $1.7B | N/A | N/A |
Not reported in any period shown, so not listed: Short-Term Investments, Accounts Receivable, Long-Term Investments.
JBS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q4'2520-F | Q3'256-K | Q4'2420-F | Q3'246-K |
|---|---|---|---|---|---|
| Operating Cash Flow | $62.8M | $1.9B+25.7% | N/A | $1.5B | N/A |
| Depreciation & Amortization | $1.3B | $623.7M+12.2% | N/A | $555.9M | N/A |
| Capital Expenditures | $1.2B | $838.3M+58.2% | N/A | $529.7M | N/A |
| Free Cash Flow | -$1.1B | $1.1B+8.6% | N/A | $1.0B | N/A |
| Investing Cash Flow | -$1.1B | -$853.5Mn/m | N/A | -$492.1M | N/A |
| Financing Cash Flow | -$141.4M | -$38.0Mn/m | N/A | -$321.0M | N/A |
| Dividends Paid | $1.0B | $0 | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Stock-Based Compensation, Share Buybacks.
JBS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q4'2520-F | Q3'256-K | Q4'2420-F | Q3'246-K |
|---|---|---|---|---|---|
| Gross Margin | 10.8% | N/A | 13.2%-3.3pp | N/A | 16.5% |
| Operating Margin | 2.5% | N/A | 5.4%-2.4pp | N/A | 7.8% |
| Net Margin | -0.4% | N/A | 2.6%-0.9pp | N/A | 3.5% |
| Return on Equity | -1.2% | N/A | 6.7%-0.6pp | N/A | 7.3% |
| Return on Assets | -0.2% | N/A | 1.3% | N/A | N/A |
| Current Ratio | 1.53 | 1.60+0.1x | 1.60 | 1.47 | N/A |
| Debt-to-Equity | 2.59 | 2.33-0.1x | 2.27 | 2.43 | N/A |
| Liabilities-to-Equity | 4.57 | 4.19-0.5x | 4.07 | 4.73 | N/A |
| Asset Turnover | 0.52 | N/A | 0.51 | N/A | N/A |
| FCF Margin | -4.7% | N/A | N/A | N/A | N/A |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| JBS N.V. JBS | FY2025 | $86.2B | $2.0B | 2.4% | $40.8B | 49/100 |
| The Kraft Heinz Company KHC | FY2025 | $24.9B | -$5.8B | -23.4% | $29.3B | 38/100 |
| General Mills, Inc. GIS | FY2026 | $18.4B | -$87.6M | -0.5% | $18.0B | 36/100 |
| McCormick & Company, Incorporated Non-VTG CS MKC | FY2025 | $6.8B | $789.4M | 11.5% | $12.9B | 50/100 |
| Hormel Foods Corporation HRL | FY2025 | $12.1B | $478.2M | 4.0% | $11.5B | 51/100 |
Where JBS N.V. Ranks
Frequently Asked Questions
What is JBS N.V.'s annual revenue?
JBS N.V. (JBS) reported $86.2B in total revenue for fiscal year 2025. This represents a 11.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is JBS N.V.'s revenue growing?
JBS N.V. (JBS) revenue grew by 11.7% year-over-year, from $77.2B to $86.2B in fiscal year 2025.
Is JBS N.V. profitable?
Yes, JBS N.V. (JBS) reported a net income of $2.0B in fiscal year 2025, with a net profit margin of 2.4%.
What is JBS N.V.'s EBITDA?
JBS N.V. (JBS) had EBITDA of $6.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does JBS N.V. have?
As of fiscal year 2025, JBS N.V. (JBS) had $4.6B in cash and equivalents against $20.3B in long-term debt.
What is JBS N.V.'s gross margin?
JBS N.V. (JBS) had a gross margin of 13.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is JBS N.V.'s operating margin?
JBS N.V. (JBS) had an operating margin of 4.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is JBS N.V.'s net profit margin?
JBS N.V. (JBS) had a net profit margin of 2.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is JBS N.V.'s return on equity (ROE)?
JBS N.V. (JBS) has a return on equity of 23.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is JBS N.V.'s free cash flow?
JBS N.V. (JBS) generated $832.7M in free cash flow during fiscal year 2025. This represents a -69.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is JBS N.V.'s operating cash flow?
JBS N.V. (JBS) generated $2.9B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are JBS N.V.'s total assets?
JBS N.V. (JBS) had $45.2B in total assets as of fiscal year 2025, including both current and long-term assets.
What are JBS N.V.'s capital expenditures?
JBS N.V. (JBS) invested $2.1B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is JBS N.V.'s current ratio?
JBS N.V. (JBS) had a current ratio of 1.60 as of fiscal year 2025, which is generally considered healthy.
What is JBS N.V.'s debt-to-equity ratio?
JBS N.V. (JBS) had a debt-to-equity ratio of 2.33 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is JBS N.V.'s liabilities-to-equity ratio?
JBS N.V. (JBS) had a liabilities-to-equity ratio of 4.19 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is JBS N.V.'s return on assets (ROA)?
JBS N.V. (JBS) had a return on assets of 4.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is JBS N.V.'s P/E ratio?
JBS N.V. (JBS) trades at 20.1x earnings, its market capitalization divided by $2.0B net income, FY2025. The market capitalization is $40.8B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is JBS N.V.'s price-to-sales ratio?
JBS N.V. (JBS) trades at 0.5x sales, its market capitalization divided by $86.2B revenue, FY2025. The market capitalization is $40.8B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is JBS N.V.'s Piotroski F-Score?
JBS N.V. (JBS) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are JBS N.V.'s earnings high quality?
JBS N.V. (JBS) has an earnings quality ratio of 1.45x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can JBS N.V. cover its interest payments?
JBS N.V. (JBS) has an interest coverage ratio of 2.48x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is JBS N.V.?
JBS N.V. (JBS) scores 49 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.